Volume 18, Number 5—May 2012
Dispatch
Coxsackievirus A21, Enterovirus 68, and Acute Respiratory Tract Infection, China
Table 2
Characteristic | No. (%) persons |
||
---|---|---|---|
Coxsackievirus A21, n = 34 | Enterovirus 68, n = 13 | Any human enterovirus, n = 130 | |
Sex | |||
M | 18 (52.9) | 7 (53.8) | 69 (53.1) |
F | 16 (47.1) | 6 (46.2) | 61 (46.9) |
Signs and symptoms | |||
Pharyngeal congestion | 34 (100) | 13 (100.0) | 128 (98.5) |
Headache | 27 (79.4) | 10 (76.9) | 104 (80.0) |
Myalgia | 25 (73.5) | 9 (69.2) | 93 (71.5) |
Chills | 25 (73.5) | 7 (53.8) | 89 (68.5) |
Sore throat | 23 (67.6) | 7 (53.8) | 82 (63.1) |
Rhinorrhea | 17 (50.0) | 5 (38.5) | 50 (38.5) |
Sneezing | 14 (41.2) | 3 (23.1) | 44 (33.8) |
Cough | 7 (20.6) | 3 (23.1) | 19 (14.6) |
Swelling of tonsils | 6 (17.6) | 1 (7.7) | 16 (12.3) |
Expectoration | 4 (11.8) | 0 | 6 (4.6) |
Rigors | 1 (2.9) | 1 (7.7) | 4 (3.1) |
Preliminary clinical diagnosis | |||
Upper respiratory tract infection | 33 (97.1) | 13 (100.0) | 126 (96.9) |
Tonsillitis | 0 | 0 | 2 (1.5) |
Pulmonary infection | 0 | 0 | 1 (0.8) |
Other viruses co-detected | 1 (2.9)† | 1 (7.7)† | 8 (6.2)‡ |
*Median age (range) of patients with coxsackievirus A21 infection, 22 (15–67) y; median age (range) of patients with enterovirus V68 infection, 34 (18–67) y; median age (range) of patients with any enterovirus infection, 27.5 (15–70) y. Median age of patients with coxsackievirus A21 infection was younger than that of patients with other human enterovirus infections (χ2 14.7; p<0.01).
†Influenza virus A (n = 1).
‡Influenza virus A (n = 2), parainfluenza virus 3 (n = 2), rhinovirus (n = 2), metapneumovirus (n = 1), coronavirus OC43 (n = 1).
Page created: April 12, 2012
Page updated: April 12, 2012
Page reviewed: April 12, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.